A pH‐responsive polymer linked with immunomodulatory drugs: synthesis, characteristics and in vitro biocompatibility

Cancer immunotherapy is a promising method for cancer therapy. Imiquimod (R837) is a molecule that could activate immune systems for cancer immunotherapy, but an easily manufactured biocompatible carrier to deliver R837 may be needed to overcome the disadvantages of R837. Micelles formed by biocompatible copolymers have been widely used to deliver chemotherapeutic drugs but not immunotherapeutic drugs. In this study, R837 was linked to an amphiphilic biodegradable copolymer mPEG‐b‐PLA via acid‐sensitive Schiff bases. The molecular structures were investigated by 1H nuclear magnetic resonance, gel permeation chromatography and Fourier transform infrared spectroscopy. The product could be self‐assembled into micelles with R837 content as high as 22.4%. Owing to acid‐cleavable Schiff bases, the release of R837 from micelles was markedly accelerated under acidic media. Consequently, the micelles linked with R837 stimulated the expression of major histocompatibility complex II‐stimulating molecules on the surface of RAW 264.7 macrophages at pH 6.5 but not pH 7.4. By using human umbilical vein endothelial cells as the in vitro model, it was shown that the polymer carriers and R837‐linked micelles were minimally cytotoxic and did not induce the activation of endothelial cells under physiological pH, which suggested the relatively high biocompatibility. In conclusion, this study successfully developed pH‐responsive immunotherapeutic drug‐loaded micelles that could activate macrophages at acidic pH in vitro. The high biocompatibility of the micelles to endothelial cells also indicated the potential uses under in vivo conditions.

[1]  Zhipeng Gu,et al.  Evaluation of toxicity of halloysite nanotubes and multi-walled carbon nanotubes to endothelial cells in vitro and blood vessels in vivo , 2020, Nanotoxicology.

[2]  L. Chablani,et al.  Immunotherapy as a second-line or later treatment modality for advanced non-small cell lung cancer: A review of safety and efficacy. , 2020, Critical reviews in oncology/hematology.

[3]  K. Leong,et al.  Engineered biomaterials for cancer immunotherapy , 2020, MedComm.

[4]  Xuesi Chen,et al.  Supramolecular Self-Assembled Nanostructures for Cancer Immunotherapy , 2020, Frontiers in Chemistry.

[5]  Peifeng Li,et al.  Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field , 2020, Nanoscale Research Letters.

[6]  A. Loskog,et al.  The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses , 2020, Frontiers in Immunology.

[7]  Chendong Ji,et al.  Enzyme-Triggered Disassembly of Perylene Monoimide-based Nanoclusters for Activatable and Deep Photodynamic Therapy. , 2020, Angewandte Chemie.

[8]  Qijuan Yuan,et al.  Non-covalent glycosylated gold nanoparticles/peptides nanovaccine as potential cancer vaccines , 2020 .

[9]  Jianxun Ding,et al.  Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery , 2020 .

[10]  Kai Yang,et al.  Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy , 2020, Nano-Micro Letters.

[11]  Robert Słotwiński,et al.  Infection-induced innate antimicrobial response disorders: from signaling pathways and their modulation to selected biomarkers , 2020, Central-European journal of immunology.

[12]  Chong Cheng,et al.  Well-Defined Diblock Poly(ethylene glycol)-b-Poly(ε-caprolactone)-Based Polymer-Drug Conjugate Micelles for pH-Responsive Delivery of Doxorubicin , 2020, Materials.

[13]  Lin Mei,et al.  pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy , 2020 .

[14]  Yuchen Wang,et al.  Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo. , 2020, Chemical communications.

[15]  Yi Cao,et al.  Titanate nanotubes at non-cytotoxic concentrations affect NO signaling pathway in human umbilical vein endothelial cells. , 2020, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  Shanshan Liu,et al.  Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. , 2020, Biomaterials.

[17]  Zhuang Liu,et al.  In Situ Formed Fibrin Scaffold with Cyclophosphamide to Synergize with Immune Checkpoint Blockade for Inhibition of Cancer Recurrence after Surgery , 2019, Advanced Functional Materials.

[18]  Binbin Xie,et al.  Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies , 2019, Molecular Cancer Therapeutics.

[19]  Shaobing Zhou,et al.  Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Yi Cao,et al.  Pharmacological and toxicological aspects of carbon nanotubes (CNTs) to vascular system: A review. , 2019, Toxicology and applied pharmacology.

[21]  Xuesi Chen,et al.  Polymer-Mediated Penetration-Independent Cancer Therapy. , 2019, Biomacromolecules.

[22]  Zhuang Liu,et al.  Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy , 2019, Science Advances.

[23]  Xuesi Chen,et al.  Multiantigenic Nanoformulations Activate Anticancer Immunity Depending on Size , 2019, Advanced Functional Materials.

[24]  M. Gou,et al.  Modular engineering of targeted dual-drug nano-assembles for cancer chemo-immunotherapy. , 2019, ACS applied materials & interfaces.

[25]  Zhuang Liu,et al.  Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Xuefei Zhang,et al.  A novel pH-sensitive polymeric prodrug was prepared by SPAAC click chemistry for intracellular delivery of doxorubicin and evaluation of its anti-cancer activity in vitro , 2019, Journal of Drug Delivery Science and Technology.

[27]  Xuesi Chen,et al.  Immunomodulatory Nanosystems , 2019, Advanced science.

[28]  Mengyu Guo,et al.  Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages , 2019, Advanced materials.

[29]  Yi Cao,et al.  The toxicity of hydroxylated and carboxylated multi-walled carbon nanotubes to human endothelial cells was not exacerbated by ER stress inducer , 2019, Chinese Chemical Letters.

[30]  Chunxi Wang,et al.  Polylactide-Cholesterol Stereocomplex Micelle Encapsulating Chemotherapeutic Agent for Improved Antitumor Efficacy and Safety. , 2018, Journal of biomedical nanotechnology.

[31]  Liming Wang,et al.  Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment , 2018, Advanced healthcare materials.

[32]  W. Han,et al.  A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer , 2018, Signal Transduction and Targeted Therapy.

[33]  Yuliang Zhao,et al.  Nucleosome-inspired nanocarrier obtains encapsulation efficiency enhancement and side effects reduction in chemotherapy by using fullerenol assembled with doxorubicin. , 2018, Biomaterials.

[34]  Binghao Bao,et al.  Co‐delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Xuefei Zhang,et al.  Preparation of dual-drug conjugated polymeric micelles with synergistic anti-cancer efficacy in vitro , 2018 .

[36]  Zhengwei Shi,et al.  Multifunctional PHPMA-Derived Polymer for Ratiometric pH Sensing, Fluorescence Imaging, and Magnetic Resonance Imaging. , 2018, ACS applied materials & interfaces.

[37]  W. Liu,et al.  ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair , 2017, Nucleic acids research.

[38]  Junfeng Shi,et al.  Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery. , 2017, Current drug metabolism.

[39]  Yi Cao,et al.  The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review , 2017, Journal of applied toxicology : JAT.

[40]  Yi Cao,et al.  The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs , 2017, Journal of Nanobiotechnology.

[41]  H. Xiang,et al.  A comparison study to investigate the effect of the drug-loading site on its delivery efficacy using double hydrophilic block copolymer-based prodrugs. , 2017, Journal of materials chemistry. B.

[42]  Xuesi Chen,et al.  Poly(β-cyclodextrin)-mediated polylactide-cholesterol stereocomplex micelles for controlled drug delivery , 2017, Chinese Journal of Polymer Science.

[43]  Xuefei Zhang,et al.  Evaluation of in vitro toxicity of polymeric micelles to human endothelial cells under different conditions. , 2017, Chemico-biological interactions.

[44]  Shanshan Cheng,et al.  The effects of endoplasmic reticulum stress inducer thapsigargin on the toxicity of ZnO or TiO2 nanoparticles to human endothelial cells , 2017, Toxicology mechanisms and methods.

[45]  Yi Cao,et al.  Foam cell formation by particulate matter (PM) exposure: a review , 2016, Inhalation toxicology.

[46]  Y. Liu,et al.  Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[47]  M. König,et al.  Biodegradable Polyphosphazene Based Peptide-Polymer Hybrids , 2016, Polymers.

[48]  Jun Cheng,et al.  Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy. , 2014, International journal of pharmaceutics.

[49]  Zhiqiang Yu,et al.  Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[50]  Han Lin,et al.  Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant , 2018 .

[51]  Min Beom Heo,et al.  Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells. , 2014, Biomaterials.